JPRN-UMIN000017713招募中2 期
Phase II study of efficiency of peripheral blood stem cell harvest in multiple myeloma patients with low-dose cyclophosphamide plus G-CSF - Phase II study of efficiency of peripheral blood stem cell harvest in multiple myeloma patients with low-dose cyclophosphamide plus G-CSF
Department of Hematology Chiba University Hospital0 个研究点目标入组 22 人开始时间: 2015年5月28日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
- 入组人数
- 22
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 70years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Patients with plasma cells in CBC 2) Pregnant or nursing women. Patients reuse to contraception during examination period 3) Patients have active other malignant diseases including simultaneous cancer and disease free state within 5 years after treatment for other cancer except curable intramural cancer by local treatment. 4) Patients with serious mental disorders 5) Patients with HBs antigen-positive 6) Patients with HIV antibody-positive 7) Patients with a history of severe allergy to the drugs 8) Patients with serious active infection 9) Patients who are considered as inappropriate to register by attending physicians
研究者
相似试验
进行中（未招募）
2 期
Adoptive Transfer of Tumor Infiltrating Lymphocytes for Advanced Solid CancersMesotheliomaNeuroendocrine TumorsSquamous Cell CancerMismatch Repair DeficiencyMicrosatellite InstabilityColorectal CancerPancreatic CancerGastric CancerSarcomaMerkel Cell CarcinomaNCT03935893Udai Kammula20
进行中（未招募）
2 期
Adoptive Transfer of Tumor Infiltrating Lymphocytes for Metastatic Uveal MelanomaUveal NeoplasmsMelanoma, UvealNCT03467516Udai Kammula34
进行中（未招募）
2 期
A clinical trial of neoadjuvant taxane chemotherapy for women with locally advanced breast cancerocally advanced breast cancerLocally advanced breast cancerCancer - BreastACTRN12606000305527The Cancer Council Victoria40
进行中（未招募）
1 期
Phase II study to evaluate 68GaNOTA-Anti-MMR-VHH2 , a new tracer for positron emission tomography (PET/CT) of macrophages in oncological, hematological and cardiovascular diseases.EUCTR2020-002483-31-BEZ Brussel140
进行中（未招募）
不适用
A phase II study to assess the efficacy of intravenous loading doses of Bondronat 6 mg on metastatic bone pain in patients with breast cancer and skeletal metastasesMetastatic bone disease related metastatic bone pain with breast as the primary site.EUCTR2006-001011-29-GRRoche (Hellas) S.A.